| Literature DB >> 33939658 |
Lauren Fishbein1, Jaydira Del Rivero2, Tobias Else3, James R Howe4, Sylvia L Asa5, Debbie L Cohen6, Patricia L M Dahia7, Douglas L Fraker8, Karyn A Goodman9, Thomas A Hope10, Pamela L Kunz11, Kimberly Perez12, Nancy D Perrier13, Daniel A Pryma14, Mabel Ryder15, Aaron R Sasson16, Michael C Soulen17, Camilo Jimenez18.
Abstract
ABSTRACT: This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management and surveillance of metastatic and unresectable pheochromocytoma and paraganglioma held on October 2 and 3, 2019. The panelists consisted of endocrinologists, medical oncologists, surgeons, radiologists/nuclear medicine physicians, nephrologists, pathologists, and radiation oncologists. The panelists performed a literature review on a series of questions regarding the medical management of metastatic and unresectable pheochromocytoma and paraganglioma as well as questions regarding surveillance after resection. The panelists voted on controversial topics, and final recommendations were sent to all panel members for final approval.Entities:
Mesh：
Year: 2021 PMID： 33939658 DOI： 10.1097/MPA.0000000000001792
Source DB: PubMed Journal: Pancreas ISSN： 0885-3177 Impact factor: 3.327